BRIEF published on 01/20/2026 at 18:05, 8 months 7 days ago THX Pharma unveils its 2026 financial calendar Euronext Paris Financial Agenda Biopharmaceutical 2026 THX Pharma
BRIEF published on 01/20/2026 at 18:05, 8 months 7 days ago THX Pharma dévoile son calendrier financier pour 2026 Calendrier Financier Maladies Neurologiques THX Pharma Annonces De 2026 Communication Marketing
BRIEF published on 01/20/2026 at 18:05, 8 months 7 days ago THX Pharma dévoile son calendrier financier 2026 Euronext Paris Agenda Financier Biopharmaceutique 2026 THX Pharma
BRIEF published on 01/20/2026 at 18:05, 8 months 7 days ago THX Pharma Reveals 2026 Financial Schedule Financial Calendar Neurological Diseases Market Communication 2026 Announcements THX Pharma
PRESS RELEASE published on 01/20/2026 at 18:00, 8 months 7 days ago THX Pharma publie son agenda financier 2026 THX Pharma publie son agenda financier 2026, incluant les dates de communication financière et informations sur ses médicaments innovants. Retrouvez plus d'informations sur http://www.theranexus.com Communication Financière Agenda Financier Médicaments Neurologiques Rares THX Pharma
PRESS RELEASE published on 01/20/2026 at 18:00, 8 months 7 days ago THX Pharma Announces its 2026 Financial Calendar THX Pharma (Theranexus) announces financial communication agenda for 2026, focusing on rare neurological diseases treatments. Company listed on Euronext Growth Paris Euronext Growth Paris Financial Communication Theranexus Neurological Diseases THX Pharma
BRIEF published on 01/08/2026 at 18:05, 8 months 19 days ago Publication de la lettre aux actionnaires par Theranexus Actionnaires Médicaments Maladies Rares Theranexus Neurosciences
BRIEF published on 01/08/2026 at 18:05, 8 months 19 days ago THX Pharma Releases Shareholder Letter Drug Development Biopharmaceutical Shareholder Communication Neurological Diseases THX Pharma
BRIEF published on 01/08/2026 at 18:05, 8 months 19 days ago Publication of the letter to shareholders by Theranexus Shareholders Neuroscience Rare Diseases Theranexus Drugs
BRIEF published on 01/08/2026 at 18:05, 8 months 19 days ago THX Pharma publie une lettre aux actionnaires Biopharmaceutique Communication Aux Actionnaires Développement De Médicaments Maladies Neurologiques THX Pharma
Published on 09/26/2026 at 01:00, 1 day 21 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 1 day 23 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 4 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 7 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/27/2026 at 17:05, 5 hours ago Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 6 hours ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 6 hours ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 6 hours ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 14 hours ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/25/2026 at 17:45, 2 days 4 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 4 hours ago Availability of the 2026 half-year financial report
